Covered recipient · General Payments record
AMY R EPPS
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2018–2024
$3,286.75
- Reported across 196 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $184.84 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $55.15 | 3 |
| E.R. Squibb & Sons, L.L.C. | $47.92 | 3 |
| Novo Nordisk AS | $22.27 | 1 |
| Penumbra, Inc. | $21.91 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $19.34 | 1 |
| GlaxoSmithKline, LLC. | $18.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $17.46 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101432281 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.44 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101432305 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.02 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101432325 | CMS |
| GlaxoSmithKline, LLC. | $18.25 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115740876 | CMS |
| Medtronic, Inc. | $18.08 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117121643 | CMS |
| Medtronic, Inc. | $18.31 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117121645 | CMS |
| Medtronic, Inc. | $18.76 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117121647 | CMS |
| Novartis Pharmaceuticals Corporation | $19.34 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086913509 | CMS |
| Novo Nordisk Inc | $22.27 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097819907 | CMS |
| Penumbra, Inc. | $21.91 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1076207240 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.